SMARCA4 and lung carcinoma: Restoration of SMARCA4 was associated with decreased lung cancer cell proliferation, metastasis, and epithelial–mesenchymal transition, an effect attributed to its positive regulatory role in the expression of miR-148b, which inhibits the WNT1/β-catenin signaling pathway [12].